CAJ | 학술논문

自身免疫性溶血性贫血(A陨匀A)是一种获得性溶血性疾病，是各种原因导致的一组月淋巴细胞功能异常亢进，产生抗自身红细胞抗体，该抗体或与红细胞表面抗原结合，或激活补体导致红细胞破坏加速，产生的溶血性贫血。多数急性起病，80豫的患儿对肾上腺皮质激素敏感，预后良好，但一部分患儿病程慢，为难治性，对激素耐药或者依赖，治疗效果不理想。本文对国内外A陨匀A的治疗方法及进展作一总结，为儿科医护人员提供相关信息和临床指导。
자신면역성용혈성빈혈(A운균A)시일충획득성용혈성질병，시각충원인도치적일조월림파세포공능이상항진，산생항자신홍세포항체，해항체혹여홍세포표면항원결합，혹격활보체도치홍세포파배가속，산생적용혈성빈혈。다수급성기병，80예적환인대신상선피질격소민감，예후량호，단일부분환인병정만，위난치성，대격소내약혹자의뢰，치료효과불이상。본문대국내외A운균A적치료방법급진전작일총결，위인과의호인원제공상관신식화림상지도。
Autoimmune hemolytic anemia (AIHA) is an acquired hemolytic disease. The antibodies of anti-own red blood cells caused by dysfunction of a group of B lymphocyte ultimately lead to hemolytic anemia. 80%patients are sensitive to adrenal cortex hormone, and have good prognosis. In addition, some cases have dependent of resistance to hormone, and the curative effects are unsatisfactory. In this study, we made a summary about the therapy and progress of AIHA in China and abroad, so as to provide basis and guidance for clinic.